Key Publications (Prof. Michael J. Schmeisser, MD PhD)

For a full list of publications please see:

https://scholar.google.de/citations?user=Fk7BvgcAAAAJ&hl=de&oi=ao

1. Colombo E, Horta G, Roesler MK, Ihbe N, Chhabra S, Radyushkin K, Di Liberto G, Kreutzfeld M, Schumann S, von Engelhardt J, Merkler D, Behl C, Mittmann T, Clement AM, Waisman A*, Schmeisser MJ*. (2021) The K63 deubiquitinase CYLD modulates autism-like behaviors and hippocampal plasticity by regulating autophagy and mTOR signaling. Proc. Natl. Sci. U.S.A. in press. (* co-senior-authors)

2. Hartig R, Wolf D, Schmeisser MJ, Kelsch W. (2021) Genetic influences of autism canidate genes on circuit wiring and olfactory decoding. Cell. Tissue. Res. 838(1);585-595 

3. Mann N, Mzoughi S, Schneider R, Kühl SJ, Schanze D, Klämbt V, Lovric S, Mao Y, Shi S, Tan W, Kühl M, Onuchic-Whitford AC, Treimer E, Kitzler TM, Kause F, Schumann S, Nakayama M, Buerger F, Shril S, ven der Ven AT, Majmundar AJ, Holton A, Wieczorek D, Gross O, Ermisch-Omran B, Werberger A, Skalej M, Janecke AR, Soliman NA, Mane SM, Lifton RP, Kadlec J, Guccione E, Schmeisser MJ, Zenker M, Hildebrandt F. (2021) Mutations in PRDM15 Are a Novel Cause of Galloway-Mowat Syndrome. J. Am. Soc. Nephrol. 32(3):580-596.

4. Rojas-Charry L, Nardi L, Methner A, Schmeisser MJ. (2021) Abnormalities of synaptic mitochondria in autism spectrum disorder and related neurodevelopmental disorders. J. Mol. Med. (Berl.). 99(2):161-178.

5. Reim D, Distler U, Halbedl S, Verpelli C, Sala C, Bockmann J, Tenzer S, Boeckers TM*, Schmeisser MJ*. (2017) Proteomic Analysis of Post-synaptic Density Fractions from Shank3 Mutant Mice Reveals Brain Region Specific Changes Relevant to Autism Spectrum Disorder. Front. Mol. Neurosci. 10:26. (* co-senior authors)

6. Reim D, Schmeisser MJ. (2017) Neurotrophic Factors in Mouse Models of Autism Spectrum Disorder: Focus on BDNF and IGF-1. Adv. Anat. Embryol. Cell. Biol. 224:121-134

7. Vicidomini C, Ponzoni L, Lim D, Schmeisser MJ, Reim D, Morello N, Orellana D, Tozzi A, Durante V, Scalmani P, Mantegazza M, Genazzani AA, Giustetto M, Sala M, Calabrasi P, Boeckers TM, Sala C, Verpelli C. (2017) Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice. Mol Psychiatry 22(5):689-702

8. Peter S, Ten Brinke MM, Stedehouder J, Reinelt CM, Wu B, Zhou H, Zouh K, Boele Hj, Kushner SA, Lee MG, Schmeisser MJ, Boeckers TM, Schoenewille M, Hoebeek FE, De Zeeuw CI. (2016) Dysfunctional cerebellar Purkinje cells contribute to autism-like behavior in Shank2-deficient mice. Nat. Commun. 7:12627.

9. Cochoy DM, Kolevzon A, Kajiwara Y, Schoen M, Pascual-Lucas M, Lurie S, Buxbaum JD, Boeckers TM, Schmeisser MJ. (2015) Phenotypic and functional analysis of SHANK3 stop mutations identified in individuals with ASD and/or ID. Mol. Autism. 6:23.

10. Schmeisser MJ*, Ey E*, Wegener S*, Bockmann J, Stempel AV, Kuebler A, Janssen AL, Udvardi PT, Shiban E, Spilker C, Balschun D, Skryabin BV, Dieck St, Smalla KH, Montag D, Leblond CS, Faure P, Torquet N, Le Sourd AM, Toro R, Grabrucker AM, Shoichet SA, Schmitz D, Kreutz MR, Bourgeron T, Gundelfinger ED, Boeckers TM. (2012) Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature. 486(7402):256-260. (*co-first authors)